Entering text into the input field will update the search result below

Can-Fite Biopharma beats by $0.01, beats on revenue

Jun. 01, 2018 7:02 AM ETCan-Fite BioPharma Ltd. (CANF) StockBy: Niloofer Shaikh, SA News Editor
  • Can-Fite Biopharma (NYSE:CANF): Q1 EPS of -$0.05 beats by $0.01.
  • Revenue of $0.63M (+800.0% Y/Y) beats by $0.49M.
  • Press Release

Recommended For You

More Trending News

About CANF Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CANF--
Can-Fite BioPharma Ltd.